Group One Trading
DFTX icon

Group One Trading’s Definium Therapeutics DFTX Stock Holding History

Group One Trading’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.06M Buy
54,000
+1,500
+3% +$63.2K ﹤0.01% 2118
2026
Q2 		$2.47M Buy
52,500
+19,800
+61% +$489K ﹤0.01% 2028
2026
Q1 		$618K Sell
32,700
-18,500
-36% -$314K ﹤0.01% 3153
2025
Q4 		$686K Buy
51,200
+9,000
+21% +$111K ﹤0.01% 3219
2025
Q3 		$498K Buy
42,200
+11,000
+35% +$103K ﹤0.01% 3709
2025
Q2 		$202K Sell
31,200
-31,200
-50% -$205K ﹤0.01% 4328
2025
Q1 		$365K Buy
62,400
+21,600
+53% +$155K ﹤0.01% 3404
2024
Q4 		$284K Buy
40,800
+10,100
+33% +$69.5K ﹤0.01% 3633
2024
Q3 		$175K Sell
30,700
-11,300
-27% -$78.6K ﹤0.01% 3751
2024
Q2 		$303K Sell
42,000
-48,400
-54% -$423K ﹤0.01% 3034
2024
Q1 		$850K Sell
90,400
-50,300
-36% -$287K ﹤0.01% 2232
2023
Q4 		$515K Buy
140,700
+16,400
+13% +$49.4K ﹤0.01% 3040
2023
Q3 		$389K Sell
124,300
-15,400
-11% -$63.3K ﹤0.01% 3169
2023
Q2 		$499K Buy
139,700
+15,900
+13% +$54.8K ﹤0.01% 3024
2023
Q1 		$392K Sell
123,800
-266,100
-68% -$885K ﹤0.01% 2990
2022
Q4 		$858K Buy
389,900
+1,400
+0.4% +$3.89K ﹤0.01% 2561
2022
Q3 		$1.36M Buy
388,500
+367,640
+1,762% +$3.53M ﹤0.01% 2258
2022
Q2 		$200K Buy
20,860
+1,587
+8% +$20.1K ﹤0.01% 4307
2022
Q1 		$321K Buy
19,273
+6,546
+51% +$114K ﹤0.01% 4299
2021
Q4 		$263K Sell
12,727
-6,833
-35% -$218K ﹤0.01% 4796
2021
Q3 		$684K Sell
19,560
-1,033
-5% -$44.7K ﹤0.01% 3841
2021
Q2 		$1.07M Buy
+20,593
New +$1.08M ﹤0.01% 3335

Other funds holding DFTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Patient Square Capital
Patient Square Capital Menlo Park, California $627M AUM 115.4% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Group One Trading's DFTX Position: Q3 2026 in Review

Group One Trading sold out of Definium Therapeutics (DFTX) in Q3 2026, closing a stake of 63,943 shares — an estimated $2.69M sold.

Group One Trading first reported a position in DFTX in Q2 2021 and held it in 13 quarters. The position peaked at $3.01M in Q2 2026. 159 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.

  • Group One Trading reported no remaining Definium Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Group One Trading sold 63,943 Definium Therapeutics shares in Q3 2026, an estimated $2.69M.
  • Group One Trading first reported a position in Definium Therapeutics in Q2 2021 and held it in 13 quarters.
  • Group One Trading's Definium Therapeutics position peaked at $3.01M in Q2 2026.
  • 159 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.

Based on Group One Trading's 13F filing for Q3 2026, filed 10 Nov 2026.